KLF17 Rabbit Polyclonal Antibody
KLF17 Polyclonal Antibody |
|||
ES10766-50ul | ELK Biotech | 50ul | 248.4 EUR |
Description: A Rabbit Polyclonal antibody against KLF17 from Human. This antibody is tested and validated for WB, ELISA, WB, ELISA |
|||
KLF17 Rabbit pAb |
|||
A13743-100ul | Abclonal | 100 ul | 369.6 EUR |
KLF17 Rabbit pAb |
|||
A13743-200ul | Abclonal | 200 ul | 550.8 EUR |
KLF17 Rabbit pAb |
|||
A13743-20ul | Abclonal | 20 ul | 219.6 EUR |
KLF17 Rabbit pAb |
|||
A13743-50ul | Abclonal | 50 ul | 267.6 EUR |
KLF17 Rabbit pAb |
|||
A9283-100ul | Abclonal | 100 ul | 369.6 EUR |
KLF17 Rabbit pAb |
|||
A9283-200ul | Abclonal | 200 ul | 550.8 EUR |
KLF17 Rabbit pAb |
|||
A9283-20ul | Abclonal | 20 ul | Ask for price |
KLF17 Rabbit pAb |
|||
A9283-50ul | Abclonal | 50 ul | Ask for price |
KLF17 antibody |
|||
70R-51411 | Fitzgerald | 100 ul | 292.8 EUR |
Description: Purified Polyclonal KLF17 antibody |
|||
KLF17 Antibody |
|||
36181-100ul | SAB | 100ul | 302.4 EUR |
KLF17 Antibody |
|||
ABD10124 | Lifescience Market | 100 ug | 525.6 EUR |
KLF17 Antibody |
|||
8041-002mg | ProSci | 0.02 mg | 206.18 EUR |
Description: KLF17, also known as ZNF393, is a member of the Sp/KLF family of transcription factors (1,2). KLF17 binds to the promoter and negatively regulates the transcription of Id-1, a key metastasis regulator in breast cancer (3). Suppression of KLF17 promotes breast cancer cell invasion and epithelial-mesenchymal transition (3). Down-regulated KLF17 expression is also associated tumor invasion and poor prognosis in hepatocellular carcinoma, suggesting that the level of KLF17 expression can serve as a prognostic indicator (4). |
|||
KLF17 Antibody |
|||
8041-01mg | ProSci | 0.1 mg | 523.7 EUR |
Description: KLF17, also known as ZNF393, is a member of the Sp/KLF family of transcription factors (1,2). KLF17 binds to the promoter and negatively regulates the transcription of Id-1, a key metastasis regulator in breast cancer (3). Suppression of KLF17 promotes breast cancer cell invasion and epithelial-mesenchymal transition (3). Down-regulated KLF17 expression is also associated tumor invasion and poor prognosis in hepatocellular carcinoma, suggesting that the level of KLF17 expression can serve as a prognostic indicator (4). |
|||
KLF17 antibody |
|||
70R-8447 | Fitzgerald | 50 ug | 560.4 EUR |
Description: Affinity purified rabbit polyclonal KLF17 antibody |
|||
KLF17 Antibody |
|||
1-CSB-PA795042 | Cusabio |
|
|
Description: A polyclonal antibody against KLF17. Recognizes KLF17 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:2000-1:5000, IHC:1:25-1:100 |
|||
KLF17 Antibody |
|||
DF10124 | Affbiotech | 200ul | 420 EUR |
KLF17 Conjugated Antibody |
|||
C36181 | SAB | 100ul | 476.4 EUR |
Anti-KLF17 antibody |
|||
PAab04601 | Lifescience Market | 100 ug | 494.4 EUR |
anti- KLF17 antibody |
|||
FNab04601 | FN Test | 100µg | 702 EUR |
Description: Antibody raised against KLF17 |
|||
Anti-KLF17 antibody |
|||
STJ111637 | St John's Laboratory | 100 µl | 332.4 EUR |
Anti-KLF17 antibody |
|||
STJ115694 | St John's Laboratory | 100 µl | 332.4 EUR |
Anti-KLF17 antibody |
|||
STJ191924 | St John's Laboratory | 200 µl | 236.4 EUR |
Description: Unconjugated Rabbit polyclonal to KLF17 |
KLF17 Rabbit Polyclonal Antibody